VEC-162 Study in Adult Patients With Primary Insomnia
Public ClinicalTrials.gov record NCT00548340. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Efficacy and Safety of VEC-162 (20 mg/Day and 50 mg/Day) in the Treatment of Primary Insomnia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of a 5 week double-blind treatment period of VEC-162 as compared to placebo in male and female patients with primary insomnia.
Study identification
- NCT ID
- NCT00548340
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 322 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2007 (Type not available)
- Primary completion
- Feb 2008 (Actual)
- Completion
- Jun 2008 (Actual)
- Last update posted
- Oct 15, 2014
2007 – 2008
United States locations
- U.S. sites
- 35
- U.S. states
- 20
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Birmingham | Alabama | — | — |
| Vanda Investigational Site | Hot Springs | Arkansas | — | — |
| Vanda Investigational Site | Little Rock | Arkansas | — | — |
| Vanda Investigational Site | Anaheim | California | — | — |
| Vanda Investigational Site | Burbank | California | — | — |
| Vanda Investigational Site | Los Angeles | California | — | — |
| Vanda Investigational Site | San Diego | California | — | — |
| Vanda Investigational Site | Santa Monica | California | — | — |
| Vanda Investigational Site | Colorado Springs | Colorado | — | — |
| Vanda Investigational Site | Hallandale | Florida | — | — |
| Vanda Investigational Site | Miami | Florida | — | — |
| Vanda Investigational Site | Naples | Florida | — | — |
| Vanda Investigational Site | Orlando | Florida | — | — |
| Vanda Investigational Site | Pembroke Pines | Florida | — | — |
| Vanda Investigational Site | St. Petersburg | Florida | — | — |
| Vanda Investigational Site | Atlanta | Georgia | — | — |
| Vanda Investigational Site | Chicago | Illinois | — | — |
| Vanda Investigational Site | Overland Park | Kansas | — | — |
| Vanda Investigational Site | Crestview Hills | Kentucky | — | — |
| Vanda Investigational Site | Lexington | Kentucky | — | — |
| Vanda Investigational Site | Louisville | Kentucky | — | — |
| Vanda Investigational Site | Chevy Chase | Maryland | — | — |
| Vanda Investigational Site | Newton | Massachusetts | — | — |
| Vanda Investigational Site | Troy | Michigan | — | — |
| Vanda Investigational Site | Chesterfield | Missouri | — | — |
| Vanda Investigational Site | Las Vegas | Nevada | — | — |
| Vanda Investigational Site | New York | New York | — | — |
| Vanda Investigational Site | West Seneca | New York | — | — |
| Vanda Investigational Site | Raleigh | North Carolina | — | — |
| Vanda Investigational Site | Beachwood | Ohio | — | — |
| Vanda Investigational Site | Cincinnati | Ohio | — | — |
| Vanda Investigational Site | Oklahoma City | Oklahoma | — | — |
| Vanda Investigational Site | Columbia | South Carolina | — | — |
| Vanda Investigational Site | Austin | Texas | — | — |
| Vanda Investigational Site | Dallas | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00548340, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2014 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00548340 live on ClinicalTrials.gov.